Arcus Biosciences, Inc.
RCUS- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001724521
In the last 90 days, Arcus Biosciences, Inc. insiders filed 0 open-market purchases and 2 sales; 231 institutions reported holding it in 13F filings for Q2 2026, worth $3.78B in total; no superinvestor holds it.
Superinvestors holding RCUS, Q2 2026
No superinvestor reported holding RCUS in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of RCUS each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2021
0 superinvestors holding at quarter end
- Sold out
- HHLR Advisors (Hillhouse)